Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer

Benjamin L. Maughan, Emmanuel S. Antonarakis, Mario A. Eisenberger et al.|Cancer Chemotherapy and Pharmacology|2016

Cited by 31